Cytogenetics and Survival of Multiple Myeloma: Isolated and Combined Effects

Theodoros Ν. Sergentanis; Efstathios Kastritis; Evangelos Terpos; Meletios A Dimopoulos; Θεοδώρα Ψαλτοπούλου

doi:10.1016/j.clml.2016.03.006

Related publications

Article1998

Prognostic value of cytogenetics in multiple myeloma

Chu‐Myong Seong, Kay Delasalle, Kimberly Hayes, Donna Weber, Meletios A Dimopoulos, Jolynn Swantkowski, Yang O. Huh, Armand B. Glassman, Richard E. Champlin, Raymond Alexanian

Article2015

Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone

Meletios A Dimopoulos, K. Weisel, Kevin Song, Michel Delforge, Lionel Karlin, Hartmut Goldschmidt, Philippe Moreau, A. Baños, Albert Oriol, L. Garderet, Michèle Cavo, V. L. Ivanova, Adrían Alegre, Joaquín Martínez‐López, Christopher Chen, Andrew Spencer, Stefan Knop, Nizar J. Bahlis, Christoph Renner, Xin Yu, Kevin Hong, Lars Sternås, Christian Jacques, Mohamed H. Zaki, Jesús F. San Miguel

Article2014

CYTOGENETICS AND LONG-TERM SURVIVAL IN MM-003, A PHASE 3 TRIAL OF POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE VS. HIGH-DOSE DEXAMETHASONE IN REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA

Meletios A Dimopoulos, Katja Weisel, Kevin Song, Michel Delforge, Lionel Karlin, Hartmut Goldschmidt, Philippe Moreau, A. Baños, Albert Oriol, Laurent Garderet, Michèle Cavo, Иванова, Adrían Alegre, Joaquín Martínez‐López, C. I Chen, A. Spencer, Stefan Knop, NJ Bahlis, C. Renner, Xiaoyan Yu, Kelvin Hong,

Article2023

P931: ISATUXIMAB IN RELAPSED MULTIPLE MYELOMA PATIENTS WITH ULTRA-HIGH-RISK CYTOGENETICS: ICARIA-MM AND IKEMA SUBGROUP ANALYSIS

Philippe Moreau, Aurore Perrot, Meletios A Dimopoulos, Thomas G. Martin, Thierry Façon, Marcelo Capra, Meral Beksaç, Nicole M. Armstrong, Franck Dubin, Sandrine Macé, Marie‐Laure Risse, Christina Tekle, Zandra Klippel, Paul G. Richardson

Article2020

Efficacy of daratumumab in the treatment of multiple myeloma with high-risk cytogenetics: Meta-analysis of randomized phase III trials.

Smith Giri, Alyssa Grimshaw, Susan Bal, Kelly Godby, Prakash Kharel, Benjamin Djulbegović, Saad Z. Usmani, Thierry Façon, Philippe Moreau, Meletios A Dimopoulos, María‐Victoria Mateos, Luciano J. Costa